Nadav Kidron - 03 Jan 2022 Form 4/A - Amendment Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Issuer symbol
ORMP
Transactions as of
03 Jan 2022
Net transactions value
-$677,165
Form type
4/A - Amendment
Filing time
11 Jan 2022, 19:30:27 UTC
Date Of Original Report
05 Jan 2022
Previous filing
30 Dec 2021
Next filing
01 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +150,000 +20% 916,481 03 Jan 2022 Direct F1
transaction ORMP Common Stock Tax liability $677,165 -48,752 -5.3% $13.89 867,729 03 Jan 2022 Direct F2
transaction ORMP Common Stock Award +63,000 +7.3% 930,729 03 Jan 2022 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORMP Stock Option (right to buy Award $0 +107,000 $0.000000 107,000 03 Jan 2022 Common Stock 107,000 $13.89 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock granted by the Issuer that vested upon grant.
F2 Payment of tax liability by withholding securities incident to the 150,000 shares of Common Stock granted on January 3, 2022.
F3 Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 15,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F4 This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Kidron, which reported that 950,729 shares of common stock are beneficially owned by him following the reported transactions. Mr. Kidron beneficially owned 930,729 shares of common stock following the reported transactions.
F5 The Stock Option will vest in 4 installments as follows: 26,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.